Multaq (dronedarone) was developed to maintain a safe heart beat rhythm in those who suffered from irregular heart beat and was approved as such by the U.S Food and Drug Administration in 2009.

In 2011, the FDA issued a warning to medical professionals that severe liver injuries were a prominent health complication associated with the use of Multaq. As a result, Multaq would be required to carry a black box warning detailing the severity of drug induced liver complications.

Have Multaq Settlements Been Awarded?

Due to the recent filing nature of most Multaq dangerous drug lawsuits, drug manufacturer Sanofi-Aventis has yet to publicly issue any settlement offers to active plaintiffs.

However, as more lawsuits are filed, it will become increasingly likely that Sanofi-Aventis will begin issuing settlement offers to Multaq dangerous drug plaintiffs.

If the amount of Multaq dangerous drug lawsuits sees a significant increase, it is possible that a class action lawsuit will become active. If this does not occur, there will be a possibility for a Multaq lawsuit multidistrict litigation to be assigned.

Oftentimes, either of these occurrences increase the chances of receiving significant settlement offers. This is due to drug manufacturers desire to avoid risky public trials incurring additional financial burden and negative awareness.

Once settlement offers are issued, it is likely that they will provide compensation for the following Multaq-related damages:

  • Costs of lawsuit incurred
  • Compensatory and general damages
  • Punitive damages
  • Special and incidental damages, including medical expenses and lost wages
  • Loss of enjoyment of life, pain and suffering, and disability
  • Wrongful death damages, if person died due to this dangerous drug

The nature of the allegations against Sanofi-Aventis — neglecting to disclose dangerous drug risks to medical professionals and consumers — could lead to a desire from the manufacturer to quickly settle cases to avoid negative headlines regarding their conduct.

How Can I Receive A Multaq Settlement?

While active lawsuit against Sanofi-Aventis have yet to field settlement offers, you must act quickly if you wish to be a part of future Multaq settlements.

With multiple rigid deadlines in place that can prevent you from receiving any form of compensation, it is vital that you discuss your legal options with an attorney who is well versed in the field.

Working with a skilled attorney is the most important factor in determining if you will be able to receive a future dangerous drug settlement.

Additionally, by beginning the process as soon as possible, you will be afforded case flexibility that may prove instrumental in securing a future dangerous drug settlement. This flexibility can allow you to more accurately decide whether it serves your best interest to join a class action lawsuit or remain a standalone lawsuit.

Those who are eligible to file a Multaq dangerous drug lawsuit have suffered from one or more of the following health complications:

  • Liver Damage
  • Liver Disease
  • Liver Failure / Hepatic Failure
  • Cardiovascular Death
  • Stroke / Cerebrovascular Accident (CVA)

Our No-Fee Promise on Multaq Cases

You can afford to have our great team of lawyers on your side. When you choose us, it literally costs nothing to get started. We promise you in writing:

  • No money to get started
  • We pay all case costs and expenses
  • No legal fees whatsoever unless you receive a settlement
  • Phone calls are always free.

Start Your Multaq Claim

Our Multaq drug lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call (866) 280-4722 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing lawsuit claims.